Pursuing new treatments for Neuroblastoma children
Organization information
Cure First
Location: Seattle, United States of America
Summary
Cure First is tackling neuroblastoma (NB), a childhood cancer for which survival is poor and current treatments are overshadowed by side effects. Despite this, NB has not attracted the focus of the pharmaceutical industry. Recently we were able to establish patient-derived organoids and to apply high-throughput robotic tools to highlight drug sensitivities. We are now raising funds to finance an in vivo study which will help validate our findings and prepare them for a clinical trial.
Project locations
United States of America